Parmax Pharma Closes Trading Window for Q2 FY27

Parmax Pharma Ltd has announced the closure of its trading window for designated persons. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from October 01, 2026, until 48 hours after the declaration of financial results for the quarter and half-year ending September 30, 2026. The specific date of the board meeting to consider these results will be communicated later.